Clinical trial
Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation
NCT04830462 is registered in ClinicalTrials.gov with Herlev and Gentofte Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation
- Lead sponsor
- Herlev and Gentofte Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 15, 2021
- Completion date
- May 1, 2023
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.